Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte

  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités

3 results

  • Active substance : aprotinine
  • Topics : Drug therapy
Filter
Topic
  • Diagnostic and therapeutic techniques (3)
  • Plus ...
    • Drug therapy (3)
    • Surgical procedures (3)
    • Plus ...
      • Operative surgical procedures (2)
      • Plastic surgery (1)
      • Gastrointestinal surgery (1)
      • Cardiac surgery (1)
      • Vascular surgery (1)
  • Diseases and conditions (3)
  • Plus ...
    • Blood and lymphatic diseases (3)
    • Plus ...
      • Blood coagulation and hemostasis disorders (3)
    • Skin and connective tissue diseases (1)
    • Heart diseases (1)
    • Plus ...
      • Myocardial ischemia (1)
Content type
  • Drugs, devices and medical acts (3)
  • Plus ...
    • Medicine (3)
Language
  • Français (3)
Active substance
  • aprotinine (3)
  • chlorure de calcium (1)
  • polysorbate 80 (1)
  • thrombine humaine (2)
 More filter Other Filter Icon
Search Export

Drugs, devices and medical acts - 3 results

  • TISSEEL (aprotinine synthétique/ fibrinogène humain/ polysorbate 80/ thrombine ...)

    Medicine - Posted on 29/5/2017 - Mis à jour le 12/6/2019
    Add to my selection

  • TRASYLOL (aprotinine), antihémorragique

    Medicine - Posted on 7/3/2022
    Add to my selection

  • ARTISS (composant 1 : solution de protéines pour colle (fibrinogène humain, ap...)

    Medicine - Posted on 14/4/2022
    Add to my selection

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
uz53gFG9TJRgfT6z